Progressive supranuclear palsy (PSP) is characterized by supranuclear palsy of gaze, axial dystonia, bradykinesia, rigidity, and a progressive dementia. Pathological changes in this disorder are generally restricted to subcortical structures, yet the type and range of cognitive deficits suggest the involvement of many cerebral regions. We examined the extent of functional impairment to cerebral cortical and subcortical structures as measured by the level of glucose metabolic activity at rest. Fourteen patients with PSP were compared to 21 normal volunteers of similar age using 18 F-2-fluoro-2-deoxy-D-glucose and positron emission tomography. Glucose metabolism was reduced in the caudate nucleus, putamen, thalamus, pons, and cerebral cortex,...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
A regional analysis of cerebral glucose metabolism was carried out in 9 patients with progressive su...
To investigate cerebral oxygen metabolism in progressive supranuclear palsy (PSP), 5 patients with a...
To investigate cerebral oxygen metabolism in progressive supranuclear palsy (PSP), 5 patients with a...
The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be...
The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be...
Normal aging, progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD) are characteri...
It remains unclear whether the supportive imaging features described in the diagnostic criteria for ...
peer reviewedThis report emphasizes the precise topographic distribution of cerebral metabolic impai...
This thesis characterises the cortical pattern of degeneration in progressivesupranuclear palsy (PSP...
We used positron emission tomography with {‘8F7fluorodeoxyglucose to study local cerebral metabolic ...
distribution of cerebral metabolic impairment in corticobasal degeneration (CBD) and the pathophysio...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...
A regional analysis of cerebral glucose metabolism was carried out in 9 patients with progressive su...
To investigate cerebral oxygen metabolism in progressive supranuclear palsy (PSP), 5 patients with a...
To investigate cerebral oxygen metabolism in progressive supranuclear palsy (PSP), 5 patients with a...
The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be...
The differentiation between progressive supranuclear palsy (PSP) and Parkinson's disease (PD) may be...
Normal aging, progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD) are characteri...
It remains unclear whether the supportive imaging features described in the diagnostic criteria for ...
peer reviewedThis report emphasizes the precise topographic distribution of cerebral metabolic impai...
This thesis characterises the cortical pattern of degeneration in progressivesupranuclear palsy (PSP...
We used positron emission tomography with {‘8F7fluorodeoxyglucose to study local cerebral metabolic ...
distribution of cerebral metabolic impairment in corticobasal degeneration (CBD) and the pathophysio...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white ma...
The differential diagnosis of neurodegenerative brain diseases on clinical grounds is difficult, esp...